识别炎症性肠病亚型:对转录组数据和基于机器学习的方法进行全面的探索
Niyati Saini1, Animesh Acharjee2,3,4
1Cancer and Genomic Sciences, School of Medical Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.
Therapeutic advances in gastroenterology
|August 14, 2025
概括
这项研究确定了炎症性肠病 (IBD) 中的三个不同的转录基因亚型,包括克罗恩病 (CD) 和性结肠炎 (UC). 这些亚型与疾病严重程度相关,为个性化IBD治疗策略铺平了道路.
科学领域:
- 基因组学就是基因组学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 炎症性肠病 (IBD),包括克罗恩病 (CD) 和性结肠炎 (UC),以慢性胃肠炎和免疫失调为特征.
- 目前IBD的分子亚型面临着跨数据集一致性的挑战,阻碍了个性化治疗.
- 显著需要强大的IBD亚型,以捕捉疾病异质性并预测临床结果.
研究的目的:
- 在性结肠炎 (UC) 和克罗恩病 (CD) 中使用大规模RNA测序数据集识别转录组亚型.
- 分析已识别的转录组亚型的分子特征和临床相关性.
- 支持个性化IBD诊断和治疗的分层方法.
主要方法:
- 来自四个潜在队列 (GSE193677,GSE186507,GSE137344,GSE235236) 的RNA测序数据的分析,其中包括2490名成人IBD患者.
- 在UC和CD患者样本中应用k-means聚类来识别转录组亚型.
- 基因组丰富,网络分析和统计测试 (Chi-square,ANOVA) 以评估分子特征和临床关联.
主要成果:
- 在UC和CD中使用k-means集群识别了三种不同的转录基因亚型.
- 用于RNA处理/DNA修复,自/压力反应或细胞骨组织的UC亚型得到了丰富.
- CD亚型显示了细胞骨重塑,蛋白质合成,压力和翻译途径的变化,其中集群3与中度至严重的疾病活动相关,而集群1与轻度疾病相关.
结论:
- 该研究成功地定义了UC和CD的三个转录组亚型,每个都有独特的分子特征.
- 这些亚型具有显著的临床相关性,特别是在疾病严重程度方面.
- 这些发现倡导基于分子亚型的IBD管理采用个性化,分层化的方法.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
420
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
420
Inflammatory Bowel Disease I: Ulcerative Colitis
324
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
324
Inflammatory Bowel Disease II: Crohn's Disease
383
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
383
Inflammatory Bowel Disease IV: Pharmacological Management
189
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
189


